← Open Payments lookup

SARAH LONG: Open Payments

NPI 1033112008 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,425 in 75 payments from 18 companies in 2025. Trend: 2023 $1,026 · 2024 $845 · 2025 $1,425

Food & beverage: $1,425
CompanyPaymentsAmount
Lilly USA, LLC11$244
ABBVIE INC.8$215
Novo Nordisk Inc13$200
PFIZER INC.12$186
Novartis Pharmaceuticals Corporation4$91
Bayer Healthcare Pharmaceuticals Inc.5$88
Salix Pharmaceuticals, a division of Bausch Health US, LLC5$81
Otsuka America Pharmaceutical, Inc.3$68
Dexcom, Inc.2$47
AstraZeneca Pharmaceuticals LP2$37

Products named: QULIPTA, ZEPBOUND, MOUNJARO, ELIQUIS, Kerendia, NURTEC ODT, Rybelsus, XIFAXAN.

Industry payments across SC — which companies pay providers there.